Health ❯ Healthcare ❯ Pharmaceuticals ❯ Weight Loss Drugs

GLP-1 Agonists

Novo Nordisk Sues Hims & Hers to Halt Compounded Wegovy Copycats

The filing escalates a broader U.S. regulatory crackdown on mass‑market compounded GLP‑1 products.

Weight Returns Quickly After Stopping GLP-1 Drugs, Oxford Review Finds

FDA Approves Wegovy Weight-Loss Pill as First Oral GLP-1 for Obesity

GLP-1 Boom Hits a Crossroads as States Cut Coverage and Next‑Gen Drugs Advance

Oval Office Event Pauses as Pharma Representative Faints During Trump’s GLP-1 Pricing Announcement

ESC Data Tie Wegovy and Mounjaro to Lower HFpEF Hospitalization and Death, With Novo Citing CV Edge for Wegovy